Need-For-Personalized-Medicine

There is a need for personalized medicine because there are some diseases which are different from each other but they have same types of symptoms. Its necessary as it can reduce adverse effect or any allergic effect. It also helps in treating a patient more effectively by advancements in genomics.

BY MAHAM BATOOL AND MAHNOOR AMJAD

A type of medication that utilizes data about an individual’s own personal qualities or proteins to analyze, or treat infection. In malignant growth, personalized medication utilizes explicit data about an individual’s tumor to help make a conclusion, plan treatment, discover how well treatment is working, or make a good expectation.

Personalized medication is the fitting of clinical treatment to the singular qualities of every patient. The methodology depends on logical discoveries in our comprehension of how an individual’s special sub-atomic level makes them vulnerable to specific infections. This equivalent research is expanding our capacity to anticipate with which clinical medicines will be protected and successful for every patient.

Personalized medication might be viewed as a process of making greater customary ways to deal with comprehension and treating sickness. Furnishing more apparatuses that are more exact, doctors can choose a treatment or treatment convention dependent on a patient’s atomic profile that may not just limit hurtful results and guarantee a more effective result, however, can likewise help in the way to deal with infection treatment.

Example of personalized medication is one of the soonest and most basic instances of customized medication came in trastuzumab. About 30% of patients with bosom malignant growth have a structure that over-communicates a protein called HER2, HER2 is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). This protein enhances the growth of cancer cells which isn’t receptive to standard treatment. Trastuzumab was endorsed for patients with HER2 positive tumors in 1998 and further exploration in 2005 indicated that its diminished repeat by 52% in blend with chemotherapy.

In pharmacogenomics, genomic data is utilized to consider singular reactions to drugs. At the point when a quality variation is related with a specific medication reaction in a patient, there is the potential for settling on clinical choices dependent on hereditary qualities by changing the dose or picking an alternate medication,

Genomics incorporates the logical investigation of complex sicknesses, for example, coronary illness, asthma, diabetes, and malignant growth on the grounds that these infections are regularly caused more by a mix of hereditary and natural elements than by singular qualities

There is a need for personalized medicine because there are some diseases which are different from each other but they have same types of symptoms. Its necessary as it can reduce adverse effect or any allergic effect. It also helps in treating a patient more effectively by advancements in genomics.  

Authors: MAHAM BATOOL AND MAHNOOR AMJAD KINNAIRD COLLEGE FOR WOMEN UNIVERSITY, LAHORE